The North News
Mankind Pharma Ltd. is set to acquire biopharma firm Bharat Serums and Vaccines for Rs 13,630 crore, in a strategic move to enhance its presence in the women’s health and fertility market segments.According to NDTV PROFIT, This acquisition will significantly expand Mankind Pharma’s portfolio and capabilities in critical health sectors. The company will purchase Bharat Serums and Vaccines Ltd. from the private equity firm Advent International, with the transaction expected to close in three to four months.
Mumbai-based Bharat Serums offers a wide range of products focusing on women’s health, oncology, and critical care, which align with Mankind Pharma’s goal of providing comprehensive healthcare solutions. The acquisition is expected to bring synergies in research and development, manufacturing, and distribution, potentially leading to innovative product offerings and improved market reach.
Rising gold prices drive demand for lightweight jewellery, flexible savings schemes and traditional designs in…
Brand opens 60th India outlet in Sector 62, adding to Tricity’s growing nightlife scene Mohali,…
iPhone 18 Pro also likely to debut; foldable one may cost around Rs 2 lakh…
Limited land in Chandigarh, changing lifestyles drive demand for premium homes in Sector 66 Mohali,…
